Roger M. Nitsch serves as President and CEO of Neurimmune which he founded in 2006 with two business partners. He is a professor emeritus at University of Zurich, where he co-directed the Institute for Regenerative Medicine. A neuroscience entrepreneur with a background in medicine, he works in drug development for neurodegenerative diseases with over 30 years of experience in Alzheimer’s disease research. A Potamkin Prize winner and Member of the German Academy of Sciences, Roger serves on the boards of LONZA, INTEGRA Biosciences, NovaGo, on the advisory board of PUREOS Bioventures, and as an executive co-organizer of the AD/PD meetings. He holds an MD degree from the University of Heidelberg and earned his post-doctoral qualification at the Massachusetts Institute of Technology and MGH at Harvard Medical School.